Susquehanna International Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67M Sell
410,000
-944,600
-70% -$145M 0.01% 1075
2025
Q4
$236M Buy
1,354,600
+375,800
+38% +$68.6M 0.03% 472
2025
Q3
$141M Sell
978,800
-100,400
-9% -$12.3M 0.02% 693
2025
Q2
$109M Buy
1,079,200
+627,800
+139% +$48M 0.02% 716
2025
Q1
$34.4M Buy
451,400
+103,800
+30% +$7.94M 0.01% 1273
2024
Q4
$24M Sell
347,600
-176,000
-34% -$12.7M ﹤0.01% 1712
2024
Q3
$38.2M Sell
523,600
-233,600
-31% -$17.2M 0.01% 1279
2024
Q2
$50.7M Buy
757,200
+680,400
+886% +$26.4M 0.01% 977
2024
Q1
$2.08M Buy
76,800
+33,300
+77% +$932K ﹤0.01% 5237
2023
Q4
$1.35M Sell
43,500
-33,800
-44% -$876K ﹤0.01% 6243
2023
Q3
$1.95M Buy
77,300
+57,700
+294% +$1.32M ﹤0.01% 5181
2023
Q2
$414K Buy
+19,600
New +$372K ﹤0.01% 8760
2022
Q4
Sell
-91,300
Closed -$1.97M 13011
2022
Q3
$1.97M Buy
91,300
+57,200
+168% +$1.37M ﹤0.01% 4956
2022
Q2
$672K Sell
34,100
-2,300
-6% -$48.2K ﹤0.01% 7534
2022
Q1
$855K Buy
+36,400
New +$846K ﹤0.01% 7540
2021
Q4
Sell
-10,000
Closed -$275K 13473
2021
Q3
$275K Buy
+10,000
New +$262K ﹤0.01% 10787
2021
Q2
Sell
-41,200
Closed -$1.4M 12897
2021
Q1
$1.4M Buy
41,200
+31,000
+304% +$1.18M ﹤0.01% 6830
2020
Q4
$340K Sell
10,200
-34,200
-77% -$1.25M ﹤0.01% 9026
2020
Q3
$1.43M Sell
44,400
-30,900
-41% -$888K ﹤0.01% 5273
2020
Q2
$2.07M Buy
75,300
+21,400
+40% +$507K ﹤0.01% 4430
2020
Q1
$864K Sell
53,900
-336,000
-86% -$7.96M ﹤0.01% 5726
2019
Q4
$9.31M Buy
389,900
+105,900
+37% +$2.15M ﹤0.01% 2168
2019
Q3
$5.01M Sell
284,000
-2,300
-0.8% -$44.4K ﹤0.01% 2723
2019
Q2
$7.33M Sell
286,300
-19,600
-6% -$546K ﹤0.01% 2245
2019
Q1
$8.89M Buy
305,900
+48,500
+19% +$1.26M ﹤0.01% 1851
2018
Q4
$3.38M Sell
257,400
-88,000
-25% -$1.4M ﹤0.01% 2766
2018
Q3
$6.98M Buy
345,400
+151,900
+79% +$3.43M ﹤0.01% 2292
2018
Q2
$4.58M Sell
193,500
-176,400
-48% -$4.54M ﹤0.01% 2817
2018
Q1
$8.33M Buy
369,900
+256,100
+225% +$6.74M ﹤0.01% 1972
2017
Q4
$3.55M Sell
113,800
-86,700
-43% -$2.56M ﹤0.01% 2977
2017
Q3
$6.26M Buy
200,500
+130,400
+186% +$2.48M ﹤0.01% 2241
2017
Q2
$1.2M Sell
70,100
-151,300
-68% -$2.58M ﹤0.01% 4884
2017
Q1
$3.88M Buy
221,400
+170,800
+338% +$2.63M ﹤0.01% 2647
2016
Q4
$669K Sell
50,600
-22,600
-31% -$308K ﹤0.01% 6371
2016
Q3
$1.06M Buy
73,200
+19,900
+37% +$249K ﹤0.01% 4696
2016
Q2
$526K Sell
53,300
-10,400
-16% -$121K ﹤0.01% 6034
2016
Q1
$807K Buy
63,700
+6,200
+11% +$81.5K ﹤0.01% 5520
2015
Q4
$1.04M Buy
57,500
+800
+1% +$14.1K ﹤0.01% 5320
2015
Q3
$1.05M Buy
56,700
+2,300
+4% +$57.4K ﹤0.01% 5634
2015
Q2
$1.33M Sell
54,400
-34,100
-39% -$774K ﹤0.01% 5578
2015
Q1
$1.84M Buy
88,500
+500
+0.6% +$8.81K ﹤0.01% 4479
2014
Q4
$1.36M Buy
88,000
+19,000
+28% +$270K ﹤0.01% 5246
2014
Q3
$900K Sell
69,000
-311,600
-82% -$4.7M ﹤0.01% 6118
2014
Q2
$7.61M Sell
380,600
-209,600
-36% -$3.1M ﹤0.01% 2458
2014
Q1
$11.2M Buy
590,200
+366,400
+164% +$6.96M 0.01% 1884
2013
Q4
$3.81M Buy
223,800
+170,100
+317% +$2.6M ﹤0.01% 3315
2013
Q3
$838K Sell
53,700
-39,600
-42% -$503K ﹤0.01% 5597
2013
Q2
$1.12M Buy
+93,300
New +$954K ﹤0.01% 4808

Other funds holding INSM

Susquehanna International Group's INSM Position: Q1 2026 in Review

Susquehanna International Group reduced its Insmed (INSM) stake by 7.9% in Q1 2026, selling an estimated $2.3M and leaving 173,630 shares worth $28.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1796.

Susquehanna International Group first reported a position in INSM in Q3 2013 and has held it in 40 quarters since. The position peaked at $34.2M in Q1 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Susquehanna International Group held 173,630 shares of Insmed worth $28.4M as of Q1 2026.
  • Susquehanna International Group sold 14,946 Insmed shares in Q1 2026, an estimated $2.3M.
  • Insmed made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1796 holding.
  • Susquehanna International Group first reported a position in Insmed in Q3 2013 and has held it in 40 quarters since.
  • Susquehanna International Group's Insmed position peaked at $34.2M in Q1 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.